60 Degrees Pharmaceuticals, Inc. Common Stock (SXTP NASDAQ) stock market data APIs
$4.1376
-0.34(-8.2%)
as of February 6, 2026
Try our APIs with
free plan!
60 Degrees Pharmaceuticals, Inc. Common Stock Financial Data Overview
Price chart is built with
Anychart
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. The company was founded in 2010 and is headquartered in Washington, District Of Columbia.
Prev. Close
4.1376
Open
3.7926
High
4.1502
Low
3.5906
52 wk Range
1.36-15.4
Market Cap
5 355 K
Shares Outstanding
1 287 K
Revenue
1 365 K
EPS
-0.67
Beta
2.959
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get 60 Degrees Pharmaceuticals, Inc. Common Stock data using free add-ons & libraries
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental Data
60 Degrees Pharmaceuticals, Inc. Common Stock Fundamental data includes:
- Net Revenue: 1 365 K
- EBITDA: -7 831 017
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get 60 Degrees Pharmaceuticals, Inc. Common Stock Earnings data
$
19.99
/mo.
What’s included:
- Latest Release: 2025-11-28
- EPS/Forecast: -0.08
Get 60 Degrees Pharmaceuticals, Inc. Common Stock End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
60 Degrees Pharmaceuticals, Inc. Common Stock News
New
Is GoodRx (GDRX) Using ARAKODA Discounts To Quietly Redefine Its Preventive Care Strategy?
In February 2026, 60 Degrees Pharmaceuticals announced a partnership with GoodRx to offer eligible U.S. consumers savings of up to 30% on ARAKODA, the only FDA-approved, once-weekly prescription malar...
60 Degrees Pharmaceuticals Expands Access to ARAKODA® with GoodRx Partnership
Sixty Degrees Pharmaceuticals GoodRx to offer prescription savings of up to 30% for ARAKODA® (tafenoquine) Collaboration designed to lower patient out-of-pocket costs and expand the reach of Compan...
Sector Update: Health Care Stocks Mixed Late Afternoon
Health care stocks were mixed late Thursday afternoon, with the NYSE Health Care Index up 0.2% and t PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Sector Update: Health Care Stocks Rise in Afternoon Trading
Health care stocks advanced Thursday afternoon, with the NYSE Health Care Index and the State Street PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
Get 60 Degrees Pharmaceuticals, Inc. Common Stock fresh news feed via Financial News API
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
